Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research
Open Access
- 8 January 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Abstract
Radiation therapy is a cornerstone in the treatment of head and neck cancer patients; actually, their management is based on clinical and radiological staging with all patients at the same stage treated in the same way. Recently the increasing knowledge in molecular characterization of head and neck cancer opens the way for a more tailored treatment. Patient outcomes could be improved by a personalized radiotherapy beyond technological and anatomical precision. Several tumor markers are under evaluation to understand their possible prognostic or predictive value. In this paper we discuss those markers specific for evaluate response to radiation therapy in head and neck cancer for a shift toward a biological personalization of radiotherapy.Keywords
This publication has 61 references indexed in Scilit:
- MR-guidance in clinical reality: current treatment challenges and future perspectivesRadiation Oncology, 2019
- Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parametersRadiotherapy and Oncology, 2017
- E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell CarcinomaClinical Cancer Research, 2017
- The future of personalised radiotherapy for head and neck cancerThe Lancet Oncology, 2017
- Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinomaInternational Journal of Cancer, 2017
- Radiation oncology in the era of precision medicineNature Reviews Cancer, 2016
- A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinomaInternational Journal of Oncology, 2014
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaNew England Journal of Medicine, 2004
- Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated typeCancer, 2003